Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04745234
Title Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kyowa Kirin, Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP

No variant requirements are available.